{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:34:18Z","timestamp":1770042858830,"version":"3.49.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015131","name":"Foundation for Sarcoidosis Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019244","name":"F-star Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019244","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.amjmed.2023.02.014","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T15:49:13Z","timestamp":1678117753000},"page":"534-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Management of Sarcoidosis in the 2020s by the Primary Care Physician"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-7985","authenticated-orcid":false,"given":"Marc A.","family":"Judson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.amjmed.2023.02.014_bib0001","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America. Analysis based on health care use","volume":"13","author":"Baughman","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"10.1016\/j.amjmed.2023.02.014_bib0002","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2023.02.014_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2018.05.003","article-title":"Sarcoidosis diagnostic score: A systematic evaluation to enhance the diagnosis of sarcoidosis","author":"Bickett","year":"2018","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.amjmed.2023.02.014_bib0004","first-page":"6","article-title":"How many organs need to be involved to diagnose sarcoidosis?: An unanswered question that, hopefully, will become irrelevant","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.amjmed.2023.02.014_bib0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2021.11.020","article-title":"The time bomb of isolated cardiac sarcoidosis: Is it ticking?","volume":"347","author":"Judson","year":"2022","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.amjmed.2023.02.014_bib0006","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.chest.2018.06.012","article-title":"The diagnosis of sarcoidosis: attempting to apply rigor to arbitrary and circular reasoning","volume":"154","author":"Judson","year":"2018","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.amjmed.2023.02.014_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/rheumatology\/keac278","article-title":"There is no diagnosis of exclusion in rheumatology","volume":"62","author":"Putman","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.amjmed.2023.02.014_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MAJ.0b013e3181b97635","article-title":"Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations","volume":"339","author":"McKinzie","year":"2010","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.amjmed.2023.02.014_bib0009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.120.1.109","article-title":"Endobronchial biopsy for sarcoidosis: a prospective study","volume":"120","author":"Shorr","year":"2001","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.amjmed.2023.02.014_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02770903.2012.747204","article-title":"Distinguishing asthma from sarcoidosis: an approach to a problem that is not always solvable","volume":"50","author":"Kalkanis","year":"2013","journal-title":"J Asthma"},{"issue":"3","key":"10.1016\/j.amjmed.2023.02.014_bib0011","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9343(99)00223-5","article-title":"Lofgren's syndrome revisited: a study of 186 patients","volume":"107","author":"Mana","year":"1999","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.amjmed.2023.02.014_bib0012","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.200807-1082OC","article-title":"Lofgren's syndrome: human leukocyte antigen strongly influences the disease course","volume":"179","author":"Grunewald","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"10.1016\/j.amjmed.2023.02.014_bib0013","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in cardiac and pulmonary sarcoidosis: JACC State-of-the-Art Review","volume":"76","author":"Trivieri","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.amjmed.2023.02.014_bib0014","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2023.02.014_bib0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","article-title":"The clinical features of sarcoidosis: a comprehensive review","volume":"49","author":"Judson","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.amjmed.2023.02.014_bib0016","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1164\/rccm.202106-1366CI","article-title":"Management of advanced pulmonary sarcoidosis","volume":"205","author":"Gupta","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.amjmed.2023.02.014_bib0017","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01747-2019","article-title":"Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry","volume":"55","author":"Shlobin","year":"2020","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.amjmed.2023.02.014_bib0018","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02396-2016","article-title":"Chronic pulmonary aspergillosis complicating sarcoidosis","volume":"49","author":"Uzunhan","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2023.02.014_bib0019","series-title":"Fitzpatrick's Dermatology in General Medicine, Vol 2","first-page":"1484","article-title":"Sarcoidosis","author":"Marchall","year":"2008"},{"issue":"5","key":"10.1016\/j.amjmed.2023.02.014_bib0020","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1055\/s-0040-1713130","article-title":"Cutaneous Sarcoidosis","volume":"41","author":"Caplan","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.amjmed.2023.02.014_bib0021","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-0030-1262213","volume":"31","author":"Baughman","year":"2010","journal-title":"Ocular sarcoidosis. Semin Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2023.02.014_bib0022","first-page":"188","article-title":"Clinical aspects of ocular sarcoidosis","volume":"10","author":"Ohara","year":"2005","journal-title":"Eur Respir Monogr"},{"key":"10.1016\/j.amjmed.2023.02.014_bib0023","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-2002-36518","article-title":"Ocular manifestations of sarcoidosis","volume":"23","author":"Bradley","year":"2002","journal-title":"Sem Resp Crit Care Med"},{"issue":"27-28","key":"10.1016\/j.amjmed.2023.02.014_bib0024","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4414\/smw.2003.10125","article-title":"Lacrimal gland involvement in sarcoidosis. The clinical features of 9 patients","volume":"133","author":"Yanardag","year":"2003","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.amjmed.2023.02.014_bib0025","first-page":"220","article-title":"Renal sarcoidosis and hypercalcemia","volume":"32","author":"Sharma","year":"2005","journal-title":"Eur Respir J Monogr"},{"issue":"4","key":"10.1016\/j.amjmed.2023.02.014_bib0026","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.161.4.755","article-title":"Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis","volume":"161","author":"Adams","year":"1985","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.amjmed.2023.02.014_bib0027","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1055\/s-0040-1709496","article-title":"Screening Sarcoidosis Patients for Occult Disease","volume":"41","author":"Judson","year":"2020","journal-title":"Sem Resp Crit Care Med"},{"issue":"5","key":"10.1016\/j.amjmed.2023.02.014_bib0028","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrcardio.2015.22","article-title":"Pathophysiology and clinical management of cardiac sarcoidosis","volume":"12","author":"Hamzeh","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"10 Pt 1","key":"10.1016\/j.amjmed.2023.02.014_bib0029","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.amjmed.2023.02.014_bib0030","first-page":"275","article-title":"Causes of death in patients with chronic sarcoidosis","volume":"33","author":"Hu","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"10.1016\/j.amjmed.2023.02.014_bib0031","first-page":"231","article-title":"Mortality in sarcoidosis. A changing pattern of the causes of death","volume":"62","author":"Huang","year":"1981","journal-title":"Eur J Respir Dis"},{"issue":"4","key":"10.1016\/j.amjmed.2023.02.014_bib0032","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2023.02.014_bib0033","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.rmed.2019.05.007","article-title":"Screening sarcoidosis patients for cardiac sarcoidosis: what the data really show","volume":"154","author":"Judson","year":"2019","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.amjmed.2023.02.014_bib0034","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1378\/chest.11-0263","article-title":"Management of cardiac sarcoidosis in the United States: a Delphi study","volume":"141","author":"Hamzeh","year":"2012","journal-title":"Chest"},{"issue":"24","key":"10.1016\/j.amjmed.2023.02.014_bib0035","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1093\/eurheartj\/ehm456","volume":"28","author":"Cooper","year":"2007","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.amjmed.2023.02.014_bib0036","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chest.2017.10.014","article-title":"Clinical course of sarcoidosis in World Trade Center-Exposed firefighters","volume":"153","author":"Hena","year":"2018","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.amjmed.2023.02.014_bib0037","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjmed.2023.02.014_bib0038","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2016.02.011","article-title":"The three tiers of screening for sarcoidosis organ involvement","volume":"113","author":"Judson","year":"2016","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.amjmed.2023.02.014_bib0039","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/intimm\/dxh328","article-title":"Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity","volume":"17","author":"van Eijk","year":"2005","journal-title":"Int Immunol"},{"issue":"4","key":"10.1016\/j.amjmed.2023.02.014_bib0040","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0272-5231(05)70416-0","article-title":"Pathology of sarcoidosis","volume":"18","author":"Sheffield","year":"1997","journal-title":"Clin Chest Med"},{"issue":"3","key":"10.1016\/j.amjmed.2023.02.014_bib0041","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02591413","article-title":"The interleukin-2\/interleukin-2 receptor system: structural, immunological, and clinical features","volume":"22","author":"Semenzato","year":"1992","journal-title":"Int J Clin Lab Res"},{"issue":"11","key":"10.1016\/j.amjmed.2023.02.014_bib0042","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","article-title":"Biomarkers in sarcoidosis","volume":"12","author":"Chopra","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.amjmed.2023.02.014_bib0043","first-page":"631","article-title":"Effects of sarcoid and steroids on angiotensin-converting enzyme","volume":"128","author":"Baughman","year":"1983","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2023.02.014_bib0044","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1378\/chest.124.1.186","article-title":"Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation","volume":"124","author":"Grutters","year":"2003","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.amjmed.2023.02.014_bib0045","first-page":"1647","article-title":"Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis","volume":"35","author":"Lewis","year":"1994","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.amjmed.2023.02.014_bib0046","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.amjmed.2023.02.014_bib0047","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.07-1178","article-title":"Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis","volume":"132","author":"Teirstein","year":"2007","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.amjmed.2023.02.014_bib0048","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2214\/ajr.182.2.1820289","article-title":"Imaging manifestations of neurosarcoidosis","volume":"182","author":"Smith","year":"2004","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.amjmed.2023.02.014_bib0049","first-page":"280","article-title":"The indications for the treatment of sarcoidosis: Well's Law","volume":"34","author":"Baughman","year":"2017","journal-title":"Sarcoidosis Vasc Diff Lung Dis"},{"issue":"6","key":"10.1016\/j.amjmed.2023.02.014_bib0050","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.amjmed.2023.02.014_bib0051","article-title":"Corticosteroids for pulmonary sarcoidosis","author":"Paramothayan","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.amjmed.2023.02.014_bib0052","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000196341","article-title":"Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases","volume":"61","author":"Mana","year":"1994","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.amjmed.2023.02.014_bib0053","first-page":"158","article-title":"The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases","volume":"17","author":"Pietinalho","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"5","key":"10.1016\/j.amjmed.2023.02.014_bib0054","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1183\/09031936.95.08050682","article-title":"Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis","volume":"8","author":"Alberts","year":"1995","journal-title":"Eur Respir J"},{"issue":"155","key":"10.1016\/j.amjmed.2023.02.014_bib0055","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0146-2019","article-title":"Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis","volume":"29","author":"Rahaghi","year":"2020","journal-title":"Eur Respir Rev"},{"issue":"5","key":"10.1016\/j.amjmed.2023.02.014_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2011.11.965","article-title":"Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease","volume":"66","author":"Haimovic","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.amjmed.2023.02.014_bib0057","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.amjmed.2023.02.014_bib0058","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","article-title":"The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis","volume":"24","author":"Lee","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"9323","key":"10.1016\/j.amjmed.2023.02.014_bib0059","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(02)08912-2","article-title":"Small fibre neuropathy in sarcoidosis","volume":"359","author":"Hoitsma","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.amjmed.2023.02.014_bib0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7224\/1537-2073-13.4.163","article-title":"Effects of meditation on pain and quality of life in multiple sclerosis and peripheral neuropathy: a pilot study","volume":"13","author":"Tavee","year":"2011","journal-title":"Int J MS Care"},{"issue":"5","key":"10.1016\/j.amjmed.2023.02.014_bib0061","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MCP.0b013e32832d0403","article-title":"Fatigue in sarcoidosis: a systematic review","volume":"15","author":"de Kleijn","year":"2009","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.amjmed.2023.02.014_bib0062","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-0030-1262216","article-title":"Quality of life in sarcoidosis: assessment and management","volume":"31","author":"De Vries","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.amjmed.2023.02.014_bib0063","first-page":"325","article-title":"Das L\u00f6fgren-Syndrom: Die akute Form der Sarkoidose [The L\u00f6fgren syndrome: acute sarcoidosis (author's transl)]","volume":"30","author":"Ponhold","year":"1977","journal-title":"Rontgenblatter"},{"issue":"3","key":"10.1016\/j.amjmed.2023.02.014_bib0064","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1378\/chest.125.3.997","article-title":"Health-related quality of life of persons with sarcoidosis","volume":"125","author":"Cox","year":"2004","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.amjmed.2023.02.014_bib0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1164\/ajrccm.163.2.2004177","article-title":"Depression in sarcoidosis","volume":"163","author":"Chang","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2023.02.014_bib0066","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.rmed.2017.11.008","article-title":"Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: a prospective follow-up study","volume":"138s","author":"Hendriks","year":"2018","journal-title":"Respir Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934323001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934323001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:30:39Z","timestamp":1757583039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934323001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0002934323001560"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2023.02.014","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Management of Sarcoidosis in the 2020s by the Primary Care Physician","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2023.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}